Clinical commentary on ‘Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis’, by Foley et al.

Andrew Chan

Research output: Contribution to journalComment/debate

Abstract

This clinical commentary discusses the occurrence of drug-induced aseptic meningitis in patients undergoing natalizumab treatment and other immunotherapies.

Original languageEnglish
Pages (from-to)1427-1429
Number of pages3
JournalMultiple Sclerosis Journal
Volume23
Issue number10
DOIs
StatePublished - 1 Sep 2017
Externally publishedYes

Keywords

  • Natalizumab
  • adverse drug reaction
  • disease-modifying therapies
  • drug-induced aseptic meningitis

Fingerprint

Dive into the research topics of 'Clinical commentary on ‘Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis’, by Foley et al.'. Together they form a unique fingerprint.

Cite this